These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Plucking the high hanging fruit: a systematic approach for targeting protein-protein interactions. Raj M; Bullock BN; Arora PS Bioorg Med Chem; 2013 Jul; 21(14):4051-7. PubMed ID: 23267671 [TBL] [Abstract][Full Text] [Related]
5. Importance of Rigidity in Designing Small Molecule Drugs To Tackle Protein-Protein Interactions (PPIs) through Stabilization of Desired Conformers. Lawson ADG; MacCoss M; Heer JP J Med Chem; 2018 May; 61(10):4283-4289. PubMed ID: 29140691 [TBL] [Abstract][Full Text] [Related]
6. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge. Scott DE; Bayly AR; Abell C; Skidmore J Nat Rev Drug Discov; 2016 Aug; 15(8):533-50. PubMed ID: 27050677 [TBL] [Abstract][Full Text] [Related]
7. A Structural Perspective on the Modulation of Protein-Protein Interactions with Small Molecules. Demirel HC; Dogan T; Tuncbag N Curr Top Med Chem; 2018; 18(8):700-713. PubMed ID: 29852872 [TBL] [Abstract][Full Text] [Related]
11. Protein-protein interactions as drug targets. Skwarczynska M; Ottmann C Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylation-Inducing Chimeric Small Molecules. Siriwardena SU; Munkanatta Godage DNP; Shoba VM; Lai S; Shi M; Wu P; Chaudhary SK; Schreiber SL; Choudhary A J Am Chem Soc; 2020 Aug; 142(33):14052-14057. PubMed ID: 32787262 [TBL] [Abstract][Full Text] [Related]
13. Rational Design of PDZ Domain Inhibitors: Discovery of Small Organic Compounds Targeting PDZ Domains. Hoffer L; Roche P; Morelli X Methods Mol Biol; 2021; 2256():277-289. PubMed ID: 34014528 [TBL] [Abstract][Full Text] [Related]
14. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Daina A; Michielin O; Zoete V Nucleic Acids Res; 2019 Jul; 47(W1):W357-W364. PubMed ID: 31106366 [TBL] [Abstract][Full Text] [Related]
15. Rationalizing the chemical space of protein-protein interaction inhibitors. Sperandio O; Reynès CH; Camproux AC; Villoutreix BO Drug Discov Today; 2010 Mar; 15(5-6):220-9. PubMed ID: 19969101 [TBL] [Abstract][Full Text] [Related]
16. Peptide-binding domains: are limp handshakes safest? Haslam NJ; Shields DC Sci Signal; 2012 Sep; 5(243):pe40. PubMed ID: 23012652 [TBL] [Abstract][Full Text] [Related]
17. Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening. Magee TV Bioorg Med Chem Lett; 2015 Jun; 25(12):2461-8. PubMed ID: 25971770 [TBL] [Abstract][Full Text] [Related]
19. New Modalities for Challenging Targets in Drug Discovery. Valeur E; Guéret SM; Adihou H; Gopalakrishnan R; Lemurell M; Waldmann H; Grossmann TN; Plowright AT Angew Chem Int Ed Engl; 2017 Aug; 56(35):10294-10323. PubMed ID: 28186380 [TBL] [Abstract][Full Text] [Related]
20. From Protein Communication to Drug Discovery. Persico M; Di Dato A; Orteca N; Fattorusso C; Novellino E; Andreoli M; Ferlini C Curr Top Med Chem; 2015; 15(20):2019-31. PubMed ID: 25986690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]